RIPK1 and metabolic dysfunction-associated steatotic liver disease: The serum levels of RIPK1 have been shown to correlate with the extent of necroptosis in an animal model of non-alcoholic fatty liver disease.15 We found that the serum levels of RIPK1 were significantly elevated in ALS patients compared to that of control individuals (Fig. 3a).